The most common complications of varicella are bacterial skin and soft-tissue infections, 23 generally due to Staphylococcus aureus and group A betahaemolytic streptococci. The aim of 24 this study was to characterize the toxin and antibiotic resistance profiles of S. aureus isolates 25 involved in varicella complications. Between 2002 and 2007, the French Reference Centre for 26
Introduction 39
Varicella is an acute, generally benign childhood disease due to varicella-zoster virus. 40 The reported frequency of serious complications is highly variable, probably owing to 41 differences in the methods of data collection, geography, living conditions, vaccine use and 42 hospital admission policies from one study to another. Overall, about 4 to 9% of cases of 43 varicella are complicated (6, 15) , and these complications account for 71 to 80% of varicella-44 related hospitalizations (5, 18, 40) . Previously healthy children account for more than 80% of 45 patients with such complications (32) . Neurological, gastrointestinal and respiratory disorders 46 are often reported (29, 32) (47) , two belonged to USA300 clone (agr1, ST8, spa-t008, luk-PV positive) (36) . 138
The three remaining isolates clustered into two unusual sequence types (ST59 and ST88). 139
140

Discussion
141
The survey of staphylococcal infections secondary to varicella highlighted that 142 i) major toxins (PVL, TSST-1 and ETA/ETB) are highly prevalent in isolates; ii) most clinical 143 manifestations were directly compatible with the classical activity of these toxins; and 144
iii) prevalence of C-MRSA was surprisingly high. As the survey was based on spontaneous 145 notifications to the French reference center, a reporting bias cannot be excluded, possibly 146 favoring cases most evocative of toxin production, particularly severe cases, or cases of 147 treatment failure. All these features match classical attributes of C-MRSA which could 148 explain an overestimation of this subgroup of S. aureus isolates in the present study. 149
Nevertheless, the patients' median age is concordant with that observed in epidemiological 150 studies of varicella bacterial superinfections (6, 18) . Moreover, the 19 isolates from Lyon's 151 hospitals that corresponded to almost all isolates from patients with varicella superinfection in 152 this geographical area were not genotypically and phenotypically different from those of the 153 overall panel of isolates, suggesting that the bias due to the spontaneous notifications to the 154 French reference centre for staphylococci, if existing, is not major. 155
The isolates harboring eta, associated or not with etb, had varied genetic backgrounds, 156 reflected by the diversity of their agr types ( Table 1) . The corresponding patients' clinical 157 manifestations (SSSS and bullous impetigo in seven and three cases, respectively) were 158 directly compatible with classical toxin activity (2, 14, 30, 38) . 159
The prevalence of PVL-positive isolates (9%) was higher than that observed in a 3- classically reported, all five isolates were associated with necrotizing infections (abscesses in 164 four cases and necrotizing fasciitis in one case) (21, 31) . 165
The most prevalent toxin gene was tst (28%). As expected, given the well-known 166 superantigenic activity of TSST-1, there were six cases of scarlet fever and two cases of toxic 167 shock syndrome (30, 34) . More surprisingly, 11 (69%) of the tst-positive isolates were 168 recovered from patients with SSTIs..These tst-positive isolates were exclusively associated 169 with non suppurative cutaneous lesions and cellulitis, contrasting with the suppurative forms 170 associated with PVL and the exfoliative forms associated with ETA and ETB. One of the 171 most interesting findings is that about half the isolates recovered from cellulitis carried tst 172 gene (Table 1 ). This suggests that tst-associated SSTIs are due more to an inflammatory 173 process than to pus production or to the direct action of the toxin. Four patients had 174 concomitant toxic manifestations (scarlet fever, n=2; TSS, n=2) and SSTIs (cellulitis, n=4). 
